Starting any new treatment can be a challenge. This site has been designed to answer your questions and help you get the most out of your treatment.
Be sure to read through this site to learn the basics about NYVEPRIA and remember to refer to it to help you better understand your treatment. Also, it is important to be honest with your healthcare team about how you are doing on this therapy. Speak to them when you have questions or concerns about your treatment plan.
What is NYVEPRIA used for?
NYVEPRIA is used to treat neutropenia (nu-tro- peen-ee-ah). Neutropenia is a condition where the body makes too few white blood cells, which may be caused by drugs used to treat cancer. Neutropenia is the most serious common side-effect of chemotherapy. Neutropenia predisposes your body to infections and prevents you from fighting them. Your doctor has decided to prescribe NYVEPRIA to you to increase the number of neutrophils (nu-tro-fils), which will fight infections.
Read More
How does NYVEPRIA work?
NYVEPRIA is not a chemotherapy, but it can sometimes be used in conjunction with chemotherapy. NYVEPRIA works by stimulating the bone marrow to make white blood cells. To make sure NYVEPRIA is working, your doctor may ask that you have regular blood tests to count the number of white blood cells. It is important to follow the doctor's instructions for these tests.
Read More
What formats are available for NYVEPRIA?
*Clinical significance is unknown.
BD UltraSafe Plus™ is a trademark of Safety Syringes, Inc. parent company is Becton, Dickinson and Company.
Read More
How will I receive NYVEPRIA?
The recommended dosage of NYVEPRIA is a single subcutaneous injection, just under the skin, of 6 mg/0.6 mL (the contents of one prefilled syringe), administered once per cycle of chemotherapy.
You must wait at least 24 hours after your course of cancer chemotherapy before injecting NYVEPRIA.
As there should be a two-week period between NYVEPRIA and your next course of cancer chemotherapy, if you miss a planned dose, consult your doctor before taking the missed dose.
Read More
How do I self-administer NYVEPRIA?
Your doctor will decide if you are able to give yourself a subcutaneous (i.e., under the skin) injection. NYVEPRIA should be injected only on the day the doctor has determined for you and should not be injected until 24 hours after receiving your last dose of chemotherapy in each cycle.
If you are injecting someone else with NYVEPRIA, it is important that you inform yourself about NYVEPRIA to know how and when to give the NYVEPRIA injection.
If you will be self-administering NYVEPRIA at home, please see the detailed
“Instructions for Use” or watch the Self-Injection Video for information on how to prepare and administer your NYVEPRIA injection.
Read More
Instructions for using the NYVEPRIA prefilled syringe
Please watch the Self-Injection Video for information on how to prepare and inject a dose of NYVEPRIA.
Remove the prefilled syringe carton from the refrigerator
Gather all the materials needed for injection and inspect the medicine and prefilled syringe
Get ready
Inject your dose of NYVEPRIA
Important: Keep skin pinched while injecting.
Important: When you remove the syringe, if it looks like the medicine is still in the syringe barrel, this means you have not received a full dose. Call your healthcare provider right away.
Check the injection site and dispose of the syringe
See the detailed “Instructions for Use” section in the Patient Information Leaflet for details on how to prepare and inject a dose of NYVEPRIA, and how to discard the prefilled syringe.
Patient Information (EN)
Patient Information (FR)
Read More
How can I reduce my risk of infection?
Neutropenia is a condition that gives you a higher risk of infection. So, while you’re taking NYVEPRIA, try to avoid infections by doing the following:
Read More
Recognize and report infections
NYVEPRIA can reduce the risk of infection, but it may not prevent all infections. An infection can still happen during the short time when your white blood cell levels are low.
Remember to report any symptoms of infection to your doctor or healthcare team.
Some of the common signs and symptoms of an infection include:
Do not take any medicines for a fever without checking first with your healthcare team.
Read More
What should I know before I take NYVEPRIA?
Important safety information
What should I know before I take NYVEPRIA?
Do not use NYVEPRIA if you are allergic to pegfilgrastim, filgrastim, any of the ingredients of NYVEPRIA, or to other products made using the bacteria Escherichia coli. Talk to your doctor if you have any questions about this information.
Before you take NYVEPRIA, tell your healthcare provider about all your medical conditions, including if:
There is a lump, swelling, or bruising at the injection site that does not go away, talk to your doctor. Occasionally, a problem may develop at the injection site.
You have sickle cell trait or sickle cell disease, tell your doctor prior to treatment. If you develop left upper abdominal pain or pain at the tip of your shoulder, tell your doctor or nurse immediately.
If you are pregnant, plan to become pregnant, think you may be pregnant, or are breastfeeding, you should consult your doctor before using NYVEPRIA.
Tell your healthcare provider about all the medicines you take, including any drugs, vitamins, minerals, natural supplements, or alternative medicines.
Read More
What are the possible side effects of NYVEPRIA?
Important safety information
What are the possible side effects of NYVEPRIA?
The most common side effect that you may experience is aching in the bones and muscles. If this occurs, it can usually be relieved with a non-acetylsalicylic acid over-the-counter pain reliever. Ask your doctor which is the most suitable one for you.
NYVEPRIA may cause side effects, including:
Your spleen may become enlarged and can rupture while taking NYVEPRIA. A ruptured spleen can cause death. The spleen is located in the upper left section of your stomach area. Call your doctor right away if you have pain in the left upper-stomach area or left shoulder-tip area. This pain could mean your spleen is enlarged or ruptured.
Serious allergic reactions
Serious allergic reactions can also happen. These reactions may cause a rash over the whole body, shortness of breath, wheezing, a drop in blood pressure (usually causing dizziness or light-headedness), swelling around the mouth or eyes, fast pulse, or sweating. If you experience an allergic reaction during the injection of NYVEPRIA, the injection should be stopped immediately.
If at any time a serious allergic reaction occurs, immediately call a doctor or emergency services (for example, call 911).
A serious lung problem called acute respiratory distress syndrome (ARDS)
Call your doctor or seek emergency care right away if you have shortness of breath, trouble breathing, or a fast rate of breathing.
Kidney injury (glomerulonephritis) has been seen in patients who received NYVEPRIA.
Call your healthcare provider right away if you experience puffiness of the face or ankles, blood in the urine or brown-coloured urine, or if you notice that you urinate less often than usual.
Cutaneous vasculitis, which presents as a rash in the skin surface that looks like purple or red spots or bumps, clusters of small dots, splotches, or hives. Your skin may also be itchy. Talk to your healthcare provider if you experience these symptoms.
Capillary leak syndrome, which can present as swelling or puffiness, and may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness. Talk to your healthcare provider if you experience these symptoms.
Severe sickle cell crisis has been associated with the use of pegfilgrastim in patients with sickle cell trait or sickle cell disease. Severe sickle cell crises, in some cases resulting in death, have also been associated with filgrastim, the parent compound of pegfilgrastim. If you have a sickle cell trait or sickle cell disease, make sure that you tell your doctor before you start taking NYVEPRIA so that the potential risks and benefits can be discussed.
Some patients experience redness, swelling, or itching at the site of injection. This may be an allergy to the ingredients in NYVEPRIA, or it may be a local reaction. If you notice any of these signs or symptoms, call your doctor.
These are not all the possible side effects you may feel when taking NYVEPRIA. If you experience any side effects not listed here, call your healthcare professional.
Read More
Preparing for my next appointment
It’s important to ask questions and let your healthcare team know if you have any concerns about your treatment.
It’s always good to keep a notebook handy so you can write down any questions or concerns that you would like to talk to your healthcare team about.
Read More
Keeping track of my injections
Refer to the image below to help remind you of the appropriate injection sites on your body. To help avoid injecting in the same spot as your previous injection, and to track your dosing schedule, keep a notebook handy to write down the day and time of each injection location.
As a reminder, you need to wait 24 hours before taking NYVEPRIA after receiving chemotherapy. For example, if your chemotherapy is during the day, you can plan on taking NYVEPRIA the following evening.
See the detailed “Instructions for Use” section in the Patient Information Leaflet for details on how to inject a dose of NYVEPRIA.
Read More
Pfizer Liaison Patient Support Program
Connecting you to resources that support your treatment and complement the care provided by your healthcare team.
To enrol into Pfizer Liaison, contact us by phone, 1-844-616-6888
(toll-free); fax, 1-844-636-6888; or email, [email protected].
* Financial assistance cannot be guaranteed.
Read More
Helpful Web Resources
American Cancer Society
Canadian Cancer Society
Stand Up to Cancer
Read More
BACK TO TOP
Safety Information +
Privacy Policy
Terms of Use
This website is intended for patients who are taking NYVEPRIA™.
NYVEPRIA™ is a trademark of Hospira, Inc. Used under license.
© 2023 Pfizer Canada ULC. All rights reserved.
PP-NYV-CAN-0010-EN
Do not use NYVEPRIA if you are allergic to pegfilgrastim, filgrastim, any of the ingredients of NYVEPRIA, or to other products made using the bacteria Escherichia coli. Talk to your doctor if you have any questions about this information.
Before you take NYVEPRIA, tell your healthcare provider about all your medical conditions, including if:
Tell your healthcare provider about all the medicines you take, including any drugs, vitamins, minerals, natural supplements, or alternative medicines.
The most common side effect that you may experience is aching in the bones and muscles. If this occurs, it can usually be relieved with a non-acetylsalicylic acid over-the-counter pain reliever. Ask your doctor which is the most suitable one for you.
NYVEPRIA may also cause other side effects, including:
Spleen rupture. Your spleen may become enlarged and can rupture while taking NYVEPRIA. A ruptured spleen can cause death. The spleen is located in the upper left section of your stomach area. Call your doctor right away if you have pain in the left upper-stomach area or left shoulder-tip area. This pain could mean your spleen is enlarged or ruptured.
Serious allergic reactions can also happen. These reactions may cause a rash over the whole body, shortness of breath, wheezing, a drop in blood pressure (usually causing dizziness or light-headedness), swelling around the mouth or eyes, fast pulse, or sweating. If you experience an allergic reaction during the injection of NYVEPRIA, the injection should be stopped immediately. If at any time a serious allergic reaction occurs, immediately call a doctor or emergency services (for example, call 911).
Low platelet counts (thrombocytopenia).
This presents as easy bruising and increased bleeding.
A serious lung problem called acute respiratory distress syndrome (ARDS). Call your doctor or seek emergency care right away if you have shortness of breath, trouble breathing, or a fast rate of breathing.
Kidney injury (glomerulonephritis) has been seen in patients who received NYVEPRIA. Call your doctor immediately if you experience puffiness in your face or ankles, blood in your urine or brown-coloured urine, or if you notice that you urinate less often than usual.
Cutaneous vasculitis. This presents as a rash in the skin surface that looks like purple or red spots or bumps, clusters of small dots, splotches, or hives. Your skin may also be itchy. Talk to your healthcare provider if you experience these symptoms.
Capillary leak syndrome. This can present as swelling or puffiness, and may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness. Talk to your healthcare provider if you experience these symptoms.
Severe sickle cell crisis has been associated with the use of pegfilgrastim in patients with sickle cell trait or sickle cell disease. Severe sickle cell crises, in some cases resulting in death, have also been associated with filgrastim, the parent compound of pegfilgrastim. If you have a sickle cell trait or sickle cell disease, make sure that you tell your doctor before you start taking NYVEPRIA so that the potential risks and benefits can be discussed.
Abnormal number of immature bone marrow cells (myelodysplastic syndrome), which could lead to a type of cancer (acute myeloid leukemia), presents as fever, bone pain, bruising, difficulty breathing, bleeding, and a general feeling of tiredness.*
Redness, swelling, or itching at the site of injection. This may be an allergy to the ingredients in NYVEPRIA, or it may be a local reaction. If you notice any of these signs or symptoms, call your doctor.
These are not all the possible side effects you may feel when taking NYVEPRIA. If you experience any side effects not listed here, call your healthcare professional.
* Adverse event in breast and lung cancer patients receiving chemotherapy and/or radiotherapy